PEA, FEDERICO
PEA, FEDERICO
DIMEC - DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
Docenti di ruolo di Ia fascia
Cefepime-enmetazobactam: first approved cefepime-β- lactamase inhibitor combination for multi-drug resistant Enterobacterales
In corso di stampa Bhowmick, Tanaya; Canton, Rafael; Pea, Federico; Quevedo, Juan; Santerre Henriksen, Anne; Timsit, Jean-François; Kaye, Keith S
Accurate and Sensitive UHPLC–Tandem Mass Spectrometry Sequential Methods for Therapeutic Drug Monitoring of Aztreonam/Avibactam in Human Plasma
2026 Trozzi, Ilaria; Giorgi, Beatrice; De Paola, Riccardo; Gatti, Milo; Pea, Federico
Aggressive joint pharmacokinetic/pharmacodynamic target attainment of TDM-guided continuous infusion meropenem-vaborbactam monotherapy: a valuable strategy for maximizing the microbiological outcome of documented KPC-producing Enterobacterales infections?
2026 Gatti, Milo; Bonazzetti, Cecilia; Secci, Benedetta; Giorgi, Beatrice; Rinaldi, Matteo; Cojutti, Pier Giorgio; Ambretti, Simone; Siniscalchi, Antonio; Tonetti, Tommaso; Viale, Pierluigi; Pea, Federico
Biliary pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime–avibactam in a case series of orthotopic liver transplant recipients
2026 Gatti, Milo; Rinaldi, Matteo; Laici, Cristiana; Ambretti, Simone; Siniscalchi, Antonio; Viale, Pierluigi; Pea, Federico
Comparison of ceftolozane-tazobactam and ceftazidime-avibactam in the treatment of MDR/DTR Pseudomonas aeruginosa infections: a systematic review and meta-analysis
2026 Gatti, Milo; De Paola, Riccardo; Giorgi, Beatrice; Pea, Federico
Evaluating oritavancin for Gram-positive infections: a systematic review of on-label and off-label use
2026 Soriano, Alex; Tascini, Carlo; Falcone, Marco; Morata, Laura; Bongiovanni, Marco; Pea, Federico; Viale, Pierluigi
Pharmacokinetic/Pharmacodynamic Analysis of High-Dose Daptomycin in Combination with Continuous Infusion Ceftobiprole in a Case Series of Documented Staphylococcal Bacteremia or Endocarditis: Is There Any Room for TDM-Guided Dosing Reduction?
2026 Cojutti, Pier Giorgio; Pascale, Renato; Grechi, Andrea; Ambretti, Simone; Viale, Pierluigi; Pea, Federico
Pharmacological approaches to overcome antimicrobial resistance to novel beta-lactams in MDR Gram-negative bacterial infections: Current practice and future directions
2026 Gatti, Milo; Pea, Federico
Raising the Bar of PK/PD Target Attainment of Beta-Lactams in Daily Clinical Practice: An Effective Strategy to Overcome Resistance Development to Novel Beta-Lactams?
2026 Gatti, Milo; Pea, Federico
Real-World Evidence and Multidrug Resistant Infections: How Can We Leverage RWE to Improve Patient Outcome with the Novel Beta-Lactam and Beta-Lactam/Beta-Lactamase Inhibitor Combinations
2026 Gatti, Milo; Pea, Federico
Two Comprehensive Liquid Chromatography High-Resolution Mass Spectrometry (UPLC-MS/MS) Multi-Methods for Real-Time Therapeutic Drug Monitoring (TDM) of Five Novel Beta-Lactams and of Fosfomycin Administered by Continuous Infusion
2026 Trozzi, Ilaria; Giorgi, Beatrice; De Paola, Riccardo; Gatti, Milo; Pea, Federico
When and How to Use Subcutaneous Antibiotics
2026 Di Bella, Stefano; Geremia, Nicholas; Pea, Federico; Zeitlinger, Markus; Sanson, Gianfranco; Monticelli, Jacopo; Bergmann, Felix; Motet, Christian; Lambotte-Buffet, Christophe; Zerbato, Verena; Gatti, Milo
A pre-post quasi-experimental study of antimicrobial stewardship exploring the impact of a multidisciplinary approach aimed at attaining an aggressive joint pharmacokinetic/pharmacodynamic target with ceftazidime/avibactam on treatment outcome of KPC-producing Klebsiella pneumoniae infections and on ceftazidime/avibactam resistance development
2025 Gatti, Milo; Rinaldi, Matteo; Cojutti, Pier Giorgio; Bonazzetti, Cecilia; Siniscalchi, Antonio; Tonetti, Tommaso; Ambretti, Simone; Tedeschi, Sara; Giannella, Maddalena; Viale, Pierluigi; Pea, Federico
A pre-post quasi-experimental study of the impact of TDM-guided aggressive pharmacokinetic/pharmacodynamic target attainment of continuous infusion ceftolozane/tazobactam monotherapy in treating severe Pseudomonas aeruginosa infections: A strategy useful for raising the bar?
2025 Gatti, M.; Rinaldi, M.; Bonazzetti, C.; Siniscalchi, A.; Tonetti, T.; Ambretti, S.; Giannella, M.; Viale, P.; Pea, F.
Can a population pharmacokinetics model built on intermittent infusions accurately predict meropenem concentrations in children receiving continuous infusions?
2025 Cheng, Lucy; Kumar, Suchita; Cojutti, Pier Giorgio; Pea, Federico; Tang Girdwood, Sonya; Morales Junior, Ronaldo
Could a Reduced Dose of 8 g of Continuous Infusion Fosfomycin Be Considered as Effective as and Safer than a Standard 16 g Dose When Combined with High-Dose Daptomycin in the Treatment of Staphylococcal osteoarticular Infections?
2025 Cojutti, Pier Giorgio; Tedeschi, Sara; Zamparini, Eleonora; Fornaro, Giacomo; Zagarrigo, Manuel; De Paolis, Massimiliano; Viale, Pierluigi; Pea, Federico
Critical reappraisal of current issues for improving the proper clinical use of the incoming beta-lactam/beta-lactamase inhibitor combinations of tomorrow
2025 Gatti, Milo; Pea, Federico
Data transparency and reproducibility in health research: bridging the gap for early-career researchers
2025 Bhakta, Sanjib; Xie, Jianping; Pea, Federico; Gillespie, Stephen H.
Diagnosis and management of invasive candidiasis in critically ill patients: SIAARTI multidisciplinary statement
2025 Cortegiani, Andrea; De Pascale, Gennaro; De Angelis, Giulia; Falcone, Marco; Ferrini, Arianna; Forniti, Arianna; Gatti, Milo; Girardis, Massimo; Grasselli, Giacomo; Pea, Federico; Rinaldi, Matteo; Sanguinetti, Maurizio; Viale, Pierluigi; Giarratano, Antonino
Feasibility of 24 h continuous-infusion cefiderocol administered by elastomeric pump in attaining an aggressive PK/PD target in the treatment of NDM-producing Klebsiella pneumoniae otomastoiditis
2025 Babich, Stella; Cojutti, Pier Giorgio; Gatti, Milo; Pea, Federico; Di Bella, Stefano; Monticelli, Jacopo